Back to RA CAPITAL MANAGEMENT, L.P.

LENZ
Showing 8 of 9 quarters

Position history for RA CAPITAL MANAGEMENT, L.P.'s holdings in LENZ THERAPEUTICS INC

RA CAPITAL MANAGEMENT, L.P. holds 4.2M shares of LENZ (LENZ THERAPEUTICS INC), worth $38.2M as of 2026-Q1. LENZ represents 0.4% of RA CAPITAL MANAGEMENT, L.P.'s portfolio.

Current Value

$38.2M

Current Shares

4.2M

Total Value Change

-$34M

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Unchanged
4.2M
0.0%
$38.2M0.4%$13.15
0
2025-Q4
Unchanged
4.2M
0.0%
$66.9M0.7%$16.12
0
2025-Q3
Unchanged
4.2M
0.0%
$194.6M2.4%$44.89
0
2025-Q2
Unchanged
4.2M
0.0%
$122.5M2.1%$30.18
0
2025-Q1
Unchanged
4.2M
0.0%
$107.4M1.8%$25.64
0
2024-Q4
Unchanged
4.2M
0.0%
$120.6M1.6%$30.07
0
2024-Q3
Unchanged
4.2M
0.0%
$99.2M1.1%$24.04
0
2024-Q2
Unchanged
4.2M
0.0%
$72.3M1.0%$17.29
0

Other major holders of LENZ: BlackRock, Inc., VANGUARD GROUP INC, FMR LLC, UBS Group AG

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used